Rex Health Ventures, which is managed by a community non-profit hospital, has invested $500,000 in Aerial Biopharma, a US-based narcolepsy treatment company. Aerial was formed in January 2011 by a team of biopharmaceutical entrepreneurs. Aerial’s investigational narcolepsy treatment is in Phase 2 clinical trials. Rex President David Strong said: “This is precisely why we created…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
